Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Seidl C. Targets for therapy of bladder cancer. Semin Nucl Med. 2020;50(2):162–170.
   PubMed Web of Science ®Google Scholar
• Lenis A, Lec P, Chamie K, et al. Bladder cancer: a review. JAMA. 2020;324(19):1980–1991.
   PubMed Web of Science ®Google Scholar
• Li F, Guo H, Wang Y, et al. Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer. Int Immunopharmacol. 2020;85:106641.
   PubMed Web of Science ®Google Scholar
• Song Y, Jin D, Chen J, et al. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer. Aging (Albany NY). 2020;12(12):12051–12073.
   PubMedGoogle Scholar
• Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability — an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11(3):220–228.
   PubMed Web of Science ®Google Scholar
• Andor N, Maley CC, Ji HP. Genomic instability in cancer: teetering on the limit of Tolerance. Cancer Res. 2017;77(9):2179–2185.
   PubMed Web of Science ®Google Scholar
• Ma L, Bajic V, Zhang Z. On the classification of long non-coding RNAs. RNA Biol. 2013;10(6):925–933.
   PubMed Web of Science ®Google Scholar
• Liu H, Wan J, Chu J. Long non-coding RNAs and endometrial cancer. Biomed Pharmacother. 2019;119:109396.
   PubMed Web of Science ®Google Scholar
• Weidle UH, Birzele F, Kollmorgen G, et al. Long non-coding RNAs and their role in metastasis. Cancer Genomics Proteomics. 2017;14(3):143–160.
   PubMed Web of Science ®Google Scholar
• Fang Y, Fullwood M, Roles F. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genomics Proteomics Bioinformatics. 2016;14(1):42–54.
   PubMed Web of Science ®Google Scholar
• Hu WL, Jin L, Xu A, et al. GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability. Nat Cell Biol. 2018;20(4):492–502.
   PubMed Web of Science ®Google Scholar
• Tracy KM, Tye CE, Ghule PN, et al. Mitotically-Associated lncRNA (MANCR) affects genomic stability and cell division in aggressive breast cancer. Mol Cancer Res. 2018;16(4):587–598.
   PubMed Web of Science ®Google Scholar
• Bao S, Zhao H, Yuan J, et al. Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer. Brief Bioinform. 2020;21(5):1742–1755.
   PubMed Web of Science ®Google Scholar
• Shen D, Zhang Y, Zheng Q, et al. A competing endogenous RNA network and an 8-lncRNA prognostic signature identify MYO16-AS1 as an oncogenic lncRNA in bladder cancer. DNA Cell Biol. 2021;40(1):26–35.
   PubMed Web of Science ®Google Scholar
• Qing L, Gu P, Liu M, et al. <p>Extracellular Matrix–related six-lncRNA signature as a novel prognostic biomarker for bladder cancer. Onco Targets Ther. 2020;40:12521–12538.
   Web of Science ®Google Scholar
• Shen Z. Genomic instability and cancer: an introduction. J Mol Cell Biol. 2011;3(1):1–3.
   PubMed Web of Science ®Google Scholar
• Duijf P, Nanayakkara D, Nones K, et al. Mechanisms of genomic instability in breast cancer. Trends Mol Med. 2019;25(7):595–611.
   PubMed Web of Science ®Google Scholar
• Tubbs A, Nussenzweig A. Endogenous DNA damage as a source of genomic instability in cancer. Cell. 2017;168(4):644–656.
   PubMed Web of Science ®Google Scholar
• Vacher S, Suybeng V, Girard E, et al. Genomic instability signature of palindromic non-coding somatic mutations in bladder cancer. Cancers (Basel). 2020;12(10):2882.
   Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal S. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981.
   PubMed Web of Science ®Google Scholar
• Wang L, Cho K, Li Y, et al. Long noncoding RNA (lncRNA)-Mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. Int J Mol Sci. 2019;20(22):5758.
   Web of Science ®Google Scholar
• Zhuang C, Ma Q, Zhuang C, et al. LncRNA GClnc1 promotes proliferation and invasion of bladder cancer through activation of MYC. The FASEB Journal. 2019;33(10):11045–11059.
   PubMed Web of Science ®Google Scholar
• Lee S, Kopp F, Chang T, et al. Noncoding RNA NORAD regulates genomic stability by sequestering PUMILIO proteins. Cell. 2016;164(1–2):69–80.
   PubMed Web of Science ®Google Scholar
• Vargas J, Hatch E, Anderson D, et al. Transient nuclear envelope rupturing during interphase in human cancer cells.. Nucleus (Austin, Tex.). 2012;3(1):88–100.
   PubMed Web of Science ®Google Scholar
• Graziano S, Kreienkamp R, Coll-Bonfill N, et al. Causes and consequences of genomic instability in laminopathies: replication stress and interferon response.. Nucleus (Austin, Tex.). 2018;9(1):258–275.
   PubMed Web of Science ®Google Scholar
• Vitale I, Galluzzi L, Castedo M, et al. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol. 2011;12(6):385–392.
   PubMed Web of Science ®Google Scholar
• Petsalaki E, Zachos G. DNA damage response proteins regulating mitotic cell division: double agents preserving genome stability. FEBS J. 2020;287(9):1700–1721.
   PubMed Web of Science ®Google Scholar
• Li J, Xu Q, Wang W, et al. MIR100HG: a credible prognostic biomarker and an oncogenic lncRNA in gastric cancer. Biosci Rep. 2019;39(4).
   Web of Science ®Google Scholar
• Wang S, Ke H, Zhang H, et al. LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci. Cell Death Dis. 2018;9(8):805.
   PubMed Web of Science ®Google Scholar
• Su X, Teng J, Jin G, et al. ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2. Biomed Pharmacothe. 2019;109:788–797.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang J, Zhao W, et al. Long non-coding RNA LINC02446 suppresses the proliferation and metastasis of bladder cancer cells by binding with EIF3G and regulating the mTOR signalling pathway. Cancer Gene Ther. 2021. DOI:10.1038/s41417-020-00285-2.
   Web of Science ®Google Scholar
• Zhang Y, Li W, Lin Z, et al. <p>The long noncoding RNA Linc01833 enhances lung adenocarcinoma progression via MiR-519e-3p/S100A4 axis. Cancer Manag Res. 2020;12:11157–11167.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Chen J, Ling J, et al. Construction of a Glycolysis-related long noncoding RNA signature for predicting survival in endometrial cancer. J Cancer. 2021;12(5):1431–1444.
   PubMed Web of Science ®Google Scholar